A molecular pathway that causes the death of key nerve cells whose loss triggers off Parkinson's disease had been identified by scientists.
The researchers in Lu's lab conducted their experiments in Drosophila, the fruit fly, to show that the mutation results in impaired activity of recently discovered molecules called microRNAs, which fine-tune protein production in cells.
Parkinsons Disease
Parkinson's disease is a neurodegenerative disease caused by progressive dopamine brain cells loss. Symptoms of Parkinson's disease are correctable to an extent.
Advertisement
This impairment, in turn, leads to the premature death of nerve cells specifically involved in the secretion of the brain chemical dopamine. The degeneration of these so-called dopaminergic nerve cells in the brain is a hallmark of Parkinson's.
"MicroRNA, whose role in the body has only recently begun to be figured out, has been implicated in cancer, cardiac dysfunction and faulty immune response," said Bingwei Lu, PhD, associate professor of pathology and the study's senior author.
![Parkinson Disease at a Younger Age Attributed to Gene Abnormality]( "Parkinson Disease at a Younger Age Attributed to Gene Abnormality")
According to a study published in the September 18, 2007, issue of Neurology, the medical journal of the American Academy of Neurology, people with a certain gene mutation
"But this is the first time it has been identified as a key player in a neurodegenerative disease."
The researchers looked at the mRNAs containing the genetic recipes for the two overproduced proteins, and predicted that they would be bound by two specific microRNAs: let-7 and miR-184.
The researchers showed that toning down the levels of these two proteins,in itself, prevented dopaminergic nerve cell death in the flies.
"The flies no longer got symptoms of Parkinson's," said Lu.
"This alone has immediate therapeutic implications. Many pharmaceutical companies are already making compounds that act on these two proteins, which in previous studies have been shown to be associated with cancer. It may be possible to take these compounds off the shelf or quickly adapt them for use in non-cancer indications such as Parkinson's."
The study will be published July 29 in Nature.
Source: ANI
Parkinson Disease at a Younger Age Attributed to Gene Abnormality
According to a study published in the September 18, 2007, issue of Neurology, the medical journal of the American Academy of Neurology, people with a certain gene mutation
Advertisement
"But this is the first time it has been identified as a key player in a neurodegenerative disease."
The researchers looked at the mRNAs containing the genetic recipes for the two overproduced proteins, and predicted that they would be bound by two specific microRNAs: let-7 and miR-184.
The researchers showed that toning down the levels of these two proteins,in itself, prevented dopaminergic nerve cell death in the flies.
"The flies no longer got symptoms of Parkinson's," said Lu.
"This alone has immediate therapeutic implications. Many pharmaceutical companies are already making compounds that act on these two proteins, which in previous studies have been shown to be associated with cancer. It may be possible to take these compounds off the shelf or quickly adapt them for use in non-cancer indications such as Parkinson's."
The study will be published July 29 in Nature.
Source: ANI
Nose may Hold Key to Parkinson's Cure
A new study from Griffith University suggests that Parkinson's patients' nose may harbour a cure for the disease.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Research News
How many people in the UK have misophonia? In a representative sample study, most people had at least some irritation upon hearing trigger sounds.
Routine eye-checkups and mass screenings enable early diagnosis and treatment of glaucoma. Late-stage glaucoma diagnosis leads to blindness.
Brain plasticity following blindness leads to superior ability in sensing signals from the heart, which has implications for bodily awareness and emotional processing.
A group of scientists were awarded £1.3 million to create a new “point of care testing” kit that detects Alzheimer's disease biomarkers.
Is there a connection between Osteoporosis and dementia? Yes, loss in bone density may be linked to an increased risk of dementia in older age.